Crinetics Pharmaceuticals (CRNX) EBITDA Margin Growth (1y) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Crinetics Pharmaceuticals | 8.73 Bn | 7.44 Bn | 10.53 Mn | 2.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.96 Mn |
| Jun 30, 2025 | 822,463.00 |
| Mar 31, 2025 | -1.94 Mn |
| Jun 30, 2024 | -1.54 Mn |
| Mar 31, 2024 | -969,801.00 |
| Sep 30, 2023 | -755,760.00 |
| Jun 30, 2023 | 444,137.00 |
| Mar 31, 2023 | -71,050.00 |
| Dec 31, 2022 | -384,217.00 |
| Dec 31, 2021 | -3.36 Mn |
| Dec 31, 2020 | 3.54 Mn |
| Mar 31, 2020 | -2.23 Mn |
| Dec 31, 2019 | -353,201.00 |
| Sep 30, 2019 | -154,302.00 |
| Mar 31, 2019 | -148,656.00 |
| Dec 31, 2018 | -73,388.00 |
| Sep 30, 2018 | -110,169.00 |
| Jun 30, 2018 | -66,752.00 |